Announcement: NIH funds follow up observational study ASPREE-XT (eXTension)
Landmark study to assess long-term health risks and benefits of prior aspirin use in elderly Landmark ASPREE study extended for five years to track study participants for long-term health outcomes after discontinuing aspirin. ASPREE-XT will investigate the long-term health in people over 70 (65 years in the US) following conclusion of ASPREE (low dose…
Details